• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良流式细胞术微球检测法检测内皮细胞微颗粒对胸痛患者的预后评估

Quantification of endothelial microparticles on modified cytometric bead assay and prognosis in chest pain patients.

机构信息

Department of Cardiology, Shanghai 9th People's Hospital, Shanghai Jiaotong University Medical School.

出版信息

Circ J. 2014;78(1):206-14. doi: 10.1253/circj.cj-13-0488. Epub 2013 Nov 8.

DOI:10.1253/circj.cj-13-0488
PMID:24200872
Abstract

BACKGROUND

Endothelial microparticles (EMPs) are vehicles released from activated or apoptotic endothelium. The aim of this study was to establish a new cytometric bead assay for EMPs and investigate the prognostic value of EMPs in chest pain patients.

METHODS AND RESULTS

We invented and verified the cytometric bead assay to quantify EMP level in vitro. A total of 80 healthy volunteers and 350 chest pain patients were recruited and the EMPs measured. The major adverse cardiovascular events (MACE) of documented coronary artery disease patients were recorded in the follow-up period. The level of EMPs statistically correlated with those of endothelin-1 (ET-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. The EMP level in healthy subjects was <300.10. The patients had a remarkably higher EMP level than healthy subjects. Diabetes mellitus, EMP, and ET-1 levels were significantly associated with future cardiovascular events in chest pain patients. There was a significantly higher event incidence in the top tertile EMP level than in the lower tertile in the acute coronary syndrome (ACS) patient group.

CONCLUSIONS

A novel EMP quantification assay has been successfully established. The EMPs in vitro and in patients were significantly correlated with ET-1 and ICAM-1 level. The patients with a higher EMP level had a higher risk of MACE. EMP level is a predictor for MACE in ACS patients.

摘要

背景

内皮细胞微粒(EMPs)是从激活或凋亡的内皮细胞释放的载体。本研究旨在建立一种新的 EMPs 细胞计数珠粒检测方法,并探讨 EMPs 在胸痛患者中的预后价值。

方法和结果

我们发明并验证了细胞计数珠粒检测方法,以体外定量 EMP 水平。共招募了 80 名健康志愿者和 350 名胸痛患者,并测量了 EMPs。在随访期间记录了有明确冠状动脉疾病患者的主要不良心血管事件(MACE)。体外研究表明,EMP 水平与内皮素-1(ET-1)和细胞间黏附分子-1(ICAM-1)水平呈统计学相关。健康受试者的 EMP 水平<300.10。患者的 EMP 水平明显高于健康受试者。糖尿病、EMP 和 ET-1 水平与胸痛患者的未来心血管事件显著相关。在急性冠状动脉综合征(ACS)患者组中,EMP 水平较高的 tertile 组的事件发生率明显高于较低 tertile 组。

结论

成功建立了一种新型 EMP 定量检测方法。体外和患者的 EMPs 与 ET-1 和 ICAM-1 水平显著相关。EMP 水平较高的患者发生 MACE 的风险更高。EMP 水平是 ACS 患者 MACE 的预测因子。

相似文献

1
Quantification of endothelial microparticles on modified cytometric bead assay and prognosis in chest pain patients.改良流式细胞术微球检测法检测内皮细胞微颗粒对胸痛患者的预后评估
Circ J. 2014;78(1):206-14. doi: 10.1253/circj.cj-13-0488. Epub 2013 Nov 8.
2
Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism.内皮微粒通过一种微小RNA-222依赖的机制降低细胞间黏附分子-1(ICAM-1)的表达。
J Cell Mol Med. 2015 Sep;19(9):2202-14. doi: 10.1111/jcmm.12607. Epub 2015 Jun 17.
3
Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction.糖尿病和冠心病患者的微粒体血管生成含量可预测内皮功能障碍网络。
Cardiovasc Diabetol. 2022 Feb 2;21(1):17. doi: 10.1186/s12933-022-01449-0.
4
Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.2型糖尿病合并冠状动脉疾病患者中血管内皮钙黏蛋白阳性内皮微粒水平升高。
J Am Coll Cardiol. 2005 May 17;45(10):1622-30. doi: 10.1016/j.jacc.2005.02.047.
5
Circulating endothelial microparticles in diabetes mellitus.糖尿病患者的循环内皮微颗粒。
Mediators Inflamm. 2010;2010:250476. doi: 10.1155/2010/250476. Epub 2010 Jun 16.
6
Increase in circulating ACE-positive endothelial microparticles during acute lung injury.急性肺损伤时循环 ACE 阳性内皮微颗粒增加。
Eur Respir J. 2019 Oct 17;54(4). doi: 10.1183/13993003.01188-2018. Print 2019 Oct.
7
High levels of circulating endothelial microparticles in patients with acute coronary syndromes.急性冠状动脉综合征患者循环内皮微粒水平升高。
Am Heart J. 2003 Jun;145(6):962-70. doi: 10.1016/S0002-8703(03)00103-0.
8
Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.体外培养的人肺微血管内皮细胞和主动脉内皮细胞释放的内皮微粒体亚型差异。
Exp Lung Res. 2013 May-Jun;39(4-5):155-61. doi: 10.3109/01902148.2013.784932. Epub 2013 Apr 3.
9
Endothelial Microparticles and Vascular Endothelial Growth Factor in Patients With Head and Neck Cancer Undergoing Radiotherapy or Radiochemotherapy.接受放疗或放化疗的头颈癌患者的内皮微粒与血管内皮生长因子
In Vivo. 2019 Mar-Apr;33(2):581-586. doi: 10.21873/invivo.11514.
10
Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction.冠状动脉内皮细胞和微粒可增加心肌梗死中血管细胞黏附分子-1的表达。
Thromb Haemost. 2015 Mar;113(3):605-16. doi: 10.1160/TH14-02-0151. Epub 2014 Nov 20.

引用本文的文献

1
Extracellular Vesicles in Atherosclerosis: State of the Art.细胞外囊泡在动脉粥样硬化中的研究进展。
Int J Mol Sci. 2023 Dec 27;25(1):388. doi: 10.3390/ijms25010388.
2
Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis.细胞外囊泡在动脉粥样硬化血栓形成中的免疫炎症驱动作用。
Cells. 2022 Jun 5;11(11):1845. doi: 10.3390/cells11111845.
3
Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases.细胞外囊泡作为慢性心血管疾病潜在诊断和/或治疗生物标志物的作用
Front Cell Dev Biol. 2022 Jan 26;10:813885. doi: 10.3389/fcell.2022.813885. eCollection 2022.
4
Microparticles and cardiovascular diseases.微粒与心血管疾病。
Ann Med. 2019 May-Jun;51(3-4):193-223. doi: 10.1080/07853890.2019.1609076. Epub 2019 Jun 17.
5
Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis.慢性应激:动脉粥样硬化中细胞凋亡的关键促进因素。
J Int Med Res. 2020 Jan;48(1):300060518814606. doi: 10.1177/0300060518814606. Epub 2019 Jan 31.
6
Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications.从液体活检中探索细胞外囊泡及其 miRNA 特征作为糖尿病微/大血管并发症的早期生物标志物的诊断潜力。
Int J Mol Sci. 2017 Sep 14;18(9):1974. doi: 10.3390/ijms18091974.
7
Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者内皮细胞和血小板衍生微粒的评估
J Clin Diagn Res. 2015 Dec;9(12):OC09-13. doi: 10.7860/JCDR/2015/14493.6920. Epub 2015 Dec 1.